Edition:
India

Sun Pharmaceutical Industries Ltd (SUN.BO)

SUN.BO on Bombay Stock Exchange

464.10INR
25 Mar 2019
Change (% chg)

Rs-9.05 (-1.91%)
Prev Close
Rs473.15
Open
Rs468.90
Day's High
Rs469.10
Day's Low
Rs461.30
Volume
216,142
Avg. Vol
1,017,098
52-wk High
Rs678.80
52-wk Low
Rs375.40

Latest Key Developments (Source: Significant Developments)

Sun Pharmaceutical Industries Unit Hikes Shareholding In PJSC Biosintez
Wednesday, 13 Mar 2019 

March 13 (Reuters) - Sun Pharmaceutical Industries Ltd ::UNIT INCREASED ITS SHAREHOLDING IN PJSC BIOSINTEZ, RUSSIA TO 96.96 PCTOF PJSC BIOSINTEZ.  Full Article

Sun Pharmaceutical Requests SEBI To "Examine Matter" Relating To Media Report
Friday, 18 Jan 2019 

Jan 18 (Reuters) - Sun Pharmaceutical Industries Ltd ::SENDS LETTER TO INDIA CAPITAL MARKETS REGULATOR ON MEDIA REPORT.SUN PHARMACEUTICAL INDUSTRIES IN LETTER SAYS REQUEST SEBI TO EXAMINE MATTER IN ENTIRETY, AND "ROLE OFSOME MEDIA HOUSES AND OTHER STAKEHOLDERS".  Full Article

Sun Pharmaceutical Industries Says U.S. FDA Grants Approval For New Drug Application To Unit
Friday, 21 Dec 2018 

Dec 21 (Reuters) - Sun Pharmaceutical Industries Ltd ::U.S. FOOD & DRUG ADMINISTRATION GRANTED APPROVAL FOR NEW DRUG APPLICATION TO A UNIT OF CO.  Full Article

India Market Regulator Chief Tyagi Says Examining Complaint Made Against Sun Pharma By Whistleblower - ET NOW
Wednesday, 12 Dec 2018 

Dec 12 (Reuters) - :INDIA MARKET REGULATOR CHIEF TYAGI SAYS STARTED ADJUDICATION PROCESS AGAINST 3 RATING COS IN IL&FS CASE - ET NOW.INDIA MARKET REGULATOR CHIEF TYAGI SAYS IN TALKS WITH CENBANK ON COMMERCIAL PAPER MARKET TRANSPARENCY - ET NOW.INDIA MARKET REGULATOR CHIEF TYAGI SAYS BOARD APPROVES CHANGES TO OFFER-FOR-SALE MECHANISM RULES - ET NOW.INDIA MARKET REGULATOR CHIEF TYAGI SAYS EXAMINING COMPLAINT MADE AGAINST SUN PHARMA <<>> BY WHISTLEBLOWER - ET NOW.  Full Article

Sun Pharmaceutical Industries Gets FDA Approval For Generic Ganirelix Acetate Injection
Monday, 3 Dec 2018 

Dec 3 (Reuters) - Sun Pharmaceutical Industries Ltd ::SAYS US FDA APPROVAL FOR GENERIC GANIRELIX ACETATE INJECTION.SUN PHARMACEUTICAL INDUSTRIES - COMMERCIALIZATION OF GENERIC GANIRELIX ACETATE INJECTION IN U.S. MARKET IS EXPECTED IN Q4FY19..  Full Article

Sun Pharmaceutical Industries Says Unit To Buy Pola Pharma Inc, Japan For 100 Mln Japanese Yen
Monday, 26 Nov 2018 

Nov 26 (Reuters) - Sun Pharmaceutical Industries Ltd ::UNIT TO BUY POLA PHARMA INC., JAPAN, FOR A CASH CONSIDERATION OF 100 MILLION JAPANESE YEN.  Full Article

India's Sun Pharmaceutical Industries Posts Sept-Qtr Loss
Tuesday, 13 Nov 2018 

Nov 13 (Reuters) - Sun Pharmaceutical Industries Ltd ::SEPT QUARTER CONSOL NET LOSS 2.19 BILLION RUPEES VERSUS PROFIT OF 9.12 BILLION RUPEES LAST YEAR.CONSENSUS FORECAST FOR SEPT QUARTER CONSOL PROFIT WAS 10.35 BILLION RUPEES.SEPT QUARTER CONSOL TOTAL REVENUE FROM OPERATIONS 69.38 BILLION RUPEES VERSUS 66.50 BILLION RUPEES LAST YEAR.SAYS SEPT QUARTER EXCEPTIONAL ITEM OF 12.14 BILLION RUPEES.  Full Article

India's Sun Pharma Sees Low Double-Digit Topline Growth In FY 2018-19 Consol Revenues
Thursday, 27 Sep 2018 

Sept 27 (Reuters) - Sun Pharmaceutical Industries Ltd ::SEES A LOW DOUBLE-DIGIT TOPLINE GROWTH IN CO'S CONSOLIDATED REVENUES FOR FISCAL 2018-19 OVER LAST YEAR.SUN PHARMACEUTICAL INDUSTRIES - EXPECT NORMALIZATION OF THE INDIA BUSINESS IN THE CURRENT YEAR POST THE DISRUPTION LAST YEAR DUE TO GST IMPLEMENTATION.SUN PHARMACEUTICAL INDUSTRIES - EXPECTING REASONABLE GROWTH IN EMERGING MARKETS BUSINESS, HOWEVER, CURRENCY FLUCTUATIONS CONTINUE TO BE A RISK.SHORT-TERM OUTLOOK FOR U.S. GENERICS MARKET CONTINUES TO BE CHALLENGING GIVEN THE PRICING PRESSURES.  Full Article

Sun Pharma Industries Gets Australian Regulator Approval For Psoriasis Drug
Friday, 21 Sep 2018 

Sept 21 (Reuters) - Sun Pharmaceutical Industries Ltd ::RECEIVED AUSTRALIAN THERAPEUTIC GOODS ADMINISTRATION APPROVAL FOR SPECIALITY PRODUCT, ILUMYA.SUN PHARMACEUTICAL INDUSTRIES- DRUG FOR TREATMENT OF ADULTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS WHO ARE CANDIDATES FOR SYSTEMIC THERAPY.  Full Article

Sun Pharma Announces U.S. FDA Approval Of Cequa To Treat Dry Eye Disease
Thursday, 16 Aug 2018 

Aug 16 (Reuters) - Sun Pharmaceutical Industries Ltd ::SUN PHARMA ANNOUNCES U.S. FDA APPROVAL OF CEQUA™ TO TREAT DRY EYE DISEASE.  Full Article